Related Experiment Videos
[Cancer metastasis and oncogenes]
1Dept. of Experimental Cell Research, Kyushu University.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|October 1, 1989
Summary
Oncogenes like N-myc and erbB-2 are linked to cancer progression. Oncogene transfer can enhance cancer metastasis by altering biomolecules involved in cell invasion and motility.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Context:
- Oncogene alterations are critical in understanding cancer metastasis.
- Specific oncogenes, such as N-myc and erbB-2, are implicated in malignant progression of human neuroblastoma and breast cancer, respectively.
- DNA transfer studies are employed to investigate the role of oncogenes in metastasis.
Purpose:
- To examine the relationship between oncogene alterations and cancer metastasis.
- To assess the impact of oncogene transfer on the metastatic potential of recipient cells.
- To identify phenotypic changes associated with oncogene-induced metastasis.
Summary:
- Amplification and overexpression of oncogenes like N-myc and erbB-2 correlate with malignant progression.
- Transfer of active ras oncogenes enhances the metastatic potential of recipient cells.
- Oncogenes (e.g., ras, fos) alter the expression of key biomolecules, including metalloproteinases, motility factors, cell attachment receptors, and histocompatibility antigens, influencing invasion, motility, and attachment.
Impact:
- Provides insights into the molecular mechanisms driving cancer metastasis.
- Highlights the role of specific oncogenes in enhancing metastatic capabilities.
- Suggests potential therapeutic targets by focusing on oncogene-induced biomolecular alterations.